(Q42945088)

11 November 2017

Tumor rejection by modulation of tumor stromal fibroblasts (English)

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

11 November 2017

Tumor Rejection by Modulation of Tumor Stromal Fibroblasts (English)

1 reference

3 April 2024

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

3 April 2024

author name string

Thomas Schüler

series ordinal

1

1 reference

11 November 2017

Sandra Körnig

series ordinal

2

1 reference

11 November 2017

Thomas Blankenstein

series ordinal

3

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

11 November 2017

17 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623905

full work available at URL

3 April 2024

https://rupress.org/jem/article-pdf/198/10/1487/1145907/jem198101487.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623905

https://europepmc.org/articles/PMC2194119

3 April 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623905

https://europepmc.org/articles/PMC2194119?pdf=render

3 April 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623905

https://rupress.org/jem/article-pdf/198/10/1487/1710493/jem198101487.pdf

3 April 2024

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

Journal of Experimental Medicine

3 April 2024

published in

1 reference

11 November 2017

198

1 reference

11 November 2017

10

1 reference

11 November 2017

1487-1493

1 reference

A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

27 May 2018

IL-13 effector functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-beta production by fibroblasts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Know thy neighbor: stromal cells can contribute oncogenic signals

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

The IL-4 receptor: signaling mechanisms and biologic functions

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Interaction between endothelial cells and the secreted cytokine drives the fate of an IL4- or an IL5-transduced tumour

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Anti-IL-4 treatment prevents dermal collagen deposition in the tight-skin mouse model of scleroderma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Inhibition of angiogenesis by interleukin 4.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Human mast cells augment fibroblast proliferation by heterotypic cell-cell adhesion and action of IL-4.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Cytokines, tumour-cell death and immunogenicity: a question of choice

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Genetic approaches to cancer immunotherapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Murine interleukin-4 displays potent anti-tumor activity in vivo

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

The paracrine role of tumour-derived mIL-4 on tumour-associated endothelium

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194119

Circulating bone marrow cells can contribute to neointimal formation

16 August 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Mitogenicity of human fibroblasts in vivo for human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Peripheral blood fibrocytes: differentiation pathway and migration to wound sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Implication of interleukin-4 in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20030849

Therapeutic effects of tumor-reactive type 1 and type 2 CD8+ T cell subpopulations in established pulmonary metastases

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14623905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Neutrophils but not eosinophils are involved in growth suppression of IL-4-secreting tumors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14623905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14623905

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

10

46

3290

1986

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

3 April 2024

14

59

5002

1999

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

3 April 2024

34

63

4095

2003

1 reference

https://api.crossref.org/works/10.1084/JEM.20030849

3 April 2024

Identifiers

DOI

10.1084/JEM.20030849

1 reference

11 November 2017

1 reference

11 November 2017

1 reference